Clinical Trial Update: A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GanedenBC30 (a probiotic) on the immune system in HIV infection and related GI symptoms; study completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Symptoms
• HIV Infection

Drugs mentioned

• GanedenBC30 (Bacillus coagulans GBI-30, 6086)

Snippet

Sponsor: AIDS Healthcare Foundation | Conditions: HIV Infection, Gastrointestinal Symptoms | Phase 2 | Status: COMPLETED | Results posted: 2019-09-11